Open Access 01-08-2019 | Chronic Inflammatory Bowel Disease | Letter
Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
Published in: Advances in Therapy | Issue 8/2019
Login to get access